Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973543 · ClinicalTrials.gov registry record · Phase 1
Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
A Phase 1 study, sponsored by Neurocrine Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01973543: Completed Phase 1 study, sponsored by Neurocrine Biosciences.
NCT01973543 is a Phase 1 study that has completed, run by Neurocrine Biosciences. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01973543, a Phase 1 study, has completed, sponsored by Neurocrine Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
Safety study of AADC gene transfer (VY-AADC01) in subjects with Parkinson's disease.
Primary Outcome
Safety and Tolerability of AADC Gene Transfer assessed by Adverse Events and Serious Adverse Events.
Interventions
- BIOLOGICAL VY-AADC01
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-10 |
| Est. Completion | 2020-01-24 |
| Phase | Phase 1 |
What the finished NCT01973543 record still lists
NCT01973543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which VY-AADC01 is the first listed.
NCT01973543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01973543 about?
NCT01973543 is a clinical study titled "Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease". Safety study of AADC gene transfer (VY-AADC01) in subjects with Parkinson's disease.
What is the current status of trial NCT01973543?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2013-10. Estimated completion is 2020-01-24.
What interventions are being tested in trial NCT01973543?
The interventions under investigation include: VY-AADC01 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01973543?
This trial is sponsored by Neurocrine Biosciences, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01973543's enrollment target sits among peer trials
15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia